* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Emerging Infectious Diseases:
Traveler's diarrhea wikipedia , lookup
Neglected tropical diseases wikipedia , lookup
Tuberculosis wikipedia , lookup
Bioterrorism wikipedia , lookup
Middle East respiratory syndrome wikipedia , lookup
Dirofilaria immitis wikipedia , lookup
Eradication of infectious diseases wikipedia , lookup
Gastroenteritis wikipedia , lookup
Hepatitis B wikipedia , lookup
Schistosomiasis wikipedia , lookup
Oesophagostomum wikipedia , lookup
Coccidioidomycosis wikipedia , lookup
African trypanosomiasis wikipedia , lookup
Hepatitis C wikipedia , lookup
Marburg virus disease wikipedia , lookup
Anaerobic infection wikipedia , lookup
Sexually transmitted infection wikipedia , lookup
Emerging Infections: Assessing the risk Dr Dilys Morgan Health Protection Agency Centre for Infections “The threat of apparently new or previously unrecognised infections is ever present” CMO, Getting Ahead of the Curve 2001 “We must do more to improve our ability to prevent, detect and control emerging, as well as resurging, microbial threats to health” USA Institute of Medicine, Microbial Threats to Health; emergence, detection and response, 2003 Global map of emerging infections [Morgens et al., Nature 2004] UK definition An emerging infectious disease can be either • a newly recognised infectious disease, or • a known disease whose reported incidence within the past 2 decades is increasing (or threatens to increase) in a specific place, or among a specific population Emerging infections include: New infections resulting from changes or evolution of existing micro-organisms Emerging infections include: Known infections spreading to new geographical areas or populations Emergence may be due to: • Recognition of a previously undetected infection • Realisation that an established disease has an infectious origin (often tumours) • Spread of a new agent Factors driving emergence 1 Ecological changes: Economic development and land use; agriculture; dams, changes in water ecosystems; deforestation & reforestation; flood/drought; climate change. [schistosomiasis, Lyme disease, RVF, Junin, hantavirus] Factors driving emergence 2 ¾ Human demographics and behaviour: HIV, spread of dengue and of HIV and other STIs ¾ International travel and commerce:. Dissemination of mosquito vectors, cholera into S America, V cholerae 0139 ¾ Technology and industry: E. coli 0157, BSE, transfusion assoc HBV & HCV, iatrogenic CJD ¾ Microbial adaptation and change: Host species shift, antigenic drift in influenza, antibiotic resistant bacteria ¾ Breakdown in public health measures: Resurgent TB and diphtheria, waterborne outbreaks of cryptosporidium The convergence model of emerging infectious disease Emergence derives from interaction of the 4 domains [Institute of Medicine, 2003] Complex ecological interactions Several factors may work together or in sequence Population movement from rural to urban; overcrowding and poor infrastructure allows establishment of new infection; the city itself may offer new avenues of spread Wet markets & integrated farming… • Optimum conditions for amplification and spread • Mixing and re-assortment Emerging infections include: Re-emerging infections - due to a reappearance of, or increase in number of cases of a known infection no longer considered to be a public health problem Global and other important emerging Infections HIV • first isolated 1983 • ~20 million deaths over 20 yrs, 38 million persons infected Hepatitis C • identified 1989 • c 200 million chronic carriers at risk of developing liver cirrhosis and/or cancer vCJD • identified 1996 • 154 cases in UK, but huge animal and human health implications Slow burn……. Or SARS • The 1st emerging disease of the 21st century • First cases in China Nov 2002, though not disclosed till Feb 2003. • International air travel = global spread • Spread by respiratory droplets • Animal reservoir (?) Total probable cases – 8422 – 11%) (deaths: 916 Detection of Emerging infections in the UK A combination of : Detecting “unusual incidents” “Horizon Scanning” and surveillance International (global) Locally International (Europe) National Threats to the UK population - horizon scanning ) Arise in UK ) Spread of existing infections into UK ) May come from new infection arising outside UK National Surveillance • Alert clinicians • Laboratory reports routine and reference • NHS Direct Symptom Surveillance • Primary care with automated exceedance score alerts • Enhanced surveillance • Networks • Weekly teleconference Horizon scanning Detection of incidents/events of potential threat to public health Systematic review of informal and formal reports and maintenance of log recording significant incidents which are then followed up “Scanning the world for informal news that gives cause to suspect an unusual disease event” “65% of the world’s first news about infectious disease events now comes from informal sources including press reports and the internet” Heymann DL. Lancet Infectious Diseases, 2001;1:345-53 Sources for Surveillance for Detection Promed CIDRAP (Centre for Infectious Diseases Research and Policy) – University of Minnesota WHO Disease Outbreak News WHO Outbreak Verification List WHO Weekly Epidemiological Record GPHIN MMWR Emerging Infectious Diseases journal Veterinary Record Eurosurveillance CDR ECDC EWRS OIE Scanning for emerging risks Monitoring & Evaluation Horizon scanning Risk Assessment Response Capacity Risk management Communication Criteria to assess public health importance • Serious health impact • Unexpectedly high rates of illness or death • Potential for spread beyond national borders • Potential for interference with international travel or trade • Strength of national capacity to contain outbreak • Suspected deliberate release Assessing the threat Most Emerging Infections are zoonotic in origin, and so assessing zoonotic potential of animal infections is crucial Human-Animal Infections and Risk Surveillance Group Multiagency group which meets every month and acts as a forum to identify and discuss infections with potential for interspecies transfer (particularly zoonotic infections) Human-Animal infections and risk surveillance group • Health Protection Agency • Defra, • Veterinary Laboratories Agency • Department of Health • Chair of National Expert Panel on New and Emerging Infections (NEPNEI) • Food Standards Agency • NPHS Wales • HP Scotland Human-Animal Infections and Risk Surveillance group 1 Hazard Identification 2 Risk assessment 3 Risk management 4 Risk communication Process of risk assessment by Human-Animal Infections and Risk Surveillance Group Identification by HPA, VLA, Defra etc of incidents with potential for interspecies/ zoonotic spread Human-animal infections and risk surveillance (HAIRS) Group More detailed preliminary assessment following compilation of further information and data by HAIRS group* Discussion and assessment* Negligible risk Negligible risk Potential risk Minuted but no further action Expert Group: qualitative risk assessment UKZG *using UK Surveillance profiles when available Include in monthly output Monitor (HAIRS) Potential risk Information and assessment communicated to DH, HPA, FSA, UKZG, ACDP, CMO, CVO etc Negligible risk Statement Monthly summaries Infectious Disease Surveillance and Monitoring System for Animal and Human Health: Summary of notable events/incidents of public health significance Monthly summary • Avian influenza • Ebola Zaire virus (ZEBOV), wave-like spread, Africa • Encephalitis, India and Nepal • Invertebrates and emerging human pathogens (Photorhabdus asymbiotica) • Poliomyelitis, wild-type and vaccinederived, (update) • Nipah virus characterisation Bangladesh 2004 • Rabies, human, vampire bats, northeast Brazil • Tick-borne encephalitis (TBE), Switzerland Assessing risk from new or emerging infections Probability of infection: the likelihood of an infectious threat causing infection in the UK human population Impact on human health: the scale of harm caused by the infectious threat in terms of morbidity and mortality Context: the broad environment, including public concern and expectations, professional knowledge and external factors including politics, in which events are occurring and decisions on responses are being made. Risk Assessment New animal infection? Expert review using template for qualitative risk assessment • Pathogen identified? • Equivalent disease in humans? • Evidence to support possible zoonotic spread? • Diagnostic tests available? • Exposure? • Would cases in humans be recognised? Assessing risk from health threats identified and reported Assessments Î • Need to be transparent, systematic and objective • Used to highlight gaps in knowledge • Used to promote risk-informed decision making • Ensure all decisions become easier to explain and justify National Expert Panel for New and Emerging Infections The Panel’s function is to identify key areas for action and to advise on priorities by: • Identifying emerging and potential infectious threats to public health both nationally and internationally • Placing emerging infections in the wider clinical and public health contexts • Advising on prevention and control measures • Prioritising areas for surveillance and for information needs • Advising on research, including technological development needs Lessons Learned ¾ Collaborative approach ¾ Rigorous risk assessment ¾ Transparency of process ¾ Risk communication New infection….. How would we deal with it today? Lessons learnt from previously emerged infections HIV • public perception early in epidemic was detrimental to control • long latent period, infectious while asymptomatic • long incubation period - not detected early Hepatitis C - Similar characteristics to HIV SARS • public panic • rapidly symptomatic • infectious only while symptomatic Previously emerged infections ¾The burdens created by new infections are unpredictable and wide ranging ¾New infections can have a significant impact on the UK, whether cases occur or not ¾The nature of a new infection affects its potential to become established in the population ¾Communication and transparent risk assessment process essential The Future • New emerging infections are inevitable • Constant vigilance is required • Expect the unexpected!